Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryo Cell International (CCEL) Research & Development (2016 - 2026)

Cryo Cell International's Research & Development history spans 17 years, with the latest figure at $65761.0 for Q1 2026.

  • Quarterly results put Research & Development at $65761.0 for Q1 2026, down 32.99% from a year ago — trailing twelve months through Feb 2026 was $343881.0 (down 58.95% YoY), and the annual figure for FY2025 was $376263.0, down 69.72%.
  • Research & Development for Q1 2026 was $65761.0 at Cryo Cell International, down from $84784.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $502889.0 in Q1 2024 to a low of $61625.0 in Q3 2025.
  • The 5-year median for Research & Development is $131711.0 (2025), against an average of $190635.6.
  • The sharpest move saw Research & Development soared 2399.1% in 2022, then crashed 80.48% in 2025.
  • Year by year, Research & Development stood at $76401.0 in 2022, then skyrocketed by 480.89% to $443808.0 in 2023, then crashed by 31.36% to $304629.0 in 2024, then tumbled by 72.17% to $84784.0 in 2025, then dropped by 22.44% to $65761.0 in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $65761.0, $84784.0, and $61625.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.